Study Summary:
This is a 17 week study to evaluate the safety, efficacy, and tolerability of a medication in patients with diarrhea predominant Irritable Bowel Syndrome.
Qualified Participants Must:
• Be 18-65 years of age
•
Have a history of IBS with diarrhea
Qualified Participants May Receive:
Physical exams, lab work, study medication and compensation once a patient is determined to qualify for the study.